Brian Hooker Testifies Before Congress On Vaccine Safety Concerns

Brian Hooker Testifies Before Congress On Vaccine Safety Concerns...

Biochemist and vaccine safety advocate Brian Hooker appeared before a House subcommittee Thursday, reigniting debate over federal health agency transparency. His testimony focused on alleged data manipulation in CDC vaccine safety studies, particularly regarding autism links—a claim that has drawn both support and skepticism.

The hearing comes as public trust in health institutions remains fragile following the pandemic. Hooker, a longtime critic of the CDC's vaccine safety research, presented what he called "statistical anomalies" in a key 2004 study that found no connection between vaccines and autism.

Republican lawmakers praised Hooker's persistence in pursuing the issue, while Democratic members questioned his methodology. The hearing coincided with new CDC data showing childhood vaccination rates have dropped to 93%—below the 95% threshold needed for herd immunity against measles.

Hooker's appearance follows his recent co-authorship of a controversial study retracted by the journal Vaccines. The retraction sparked outrage among vaccine skeptics but was supported by mainstream scientists who cited methodological flaws.

Public health experts warn the hearing could fuel vaccine hesitancy as schools report rising measles cases. The CDC confirmed 45 measles cases across 17 states so far this year—more than double last year's total at this time.

Social media engagement around Hooker's testimony spiked Thursday, with #VaccineTransparency trending on Twitter. Both supporters and critics amplified their positions, reflecting the polarized nature of vaccine debates in America.

The White House declined to comment directly on the hearing but reiterated President Harris's support for "science-based vaccine policies." Meanwhile, pharmaceutical stocks dipped slightly amid the renewed controversy.

Hooker's testimony marks the latest development in his 20-year campaign questioning vaccine safety. While his claims remain outside scientific consensus, they continue finding receptive audiences among some parent groups and lawmakers.